CompoAtlas

HE Lavandin

Food supplement declared in France, declaration No 2019-2-260, decision dated 7 February 2019

HE Lavandin is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
un MAS en PROVENCE
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Compte-gouttes
Daily dose
4 gouttes
Directions for use
1 à 2 gouttes sur un comprimé neutre (ou 1 cuillère de miel), 2 fois par jour
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes

Declaration 161802, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Lavandula x htrophylla Viv.Essence (fleur)Distillation0.2 ml

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

Ne pas utiliser chez la femme enceinte ou allaitante, ni chez l'enfant de moins de 6 ans. Consultez un professionnel de santé.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

List recorded in 2019. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line